Trial intelligence / Profile preview

PK Study of Patiromer with Tacrolimus and MMF in Kidney Transplant

NCT03229265Phase 4Completed

Sponsor
Rogosin Institute
Start
Aug 2017
Primary completion
Aug 2019
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of patiromer in hyperkalemia, sponsored by Rogosin Institute. Started Aug 2017; status: completed.

02

Drugs

patiromer
03

Conditions

hyperkalemia

Beyond the preview

Go deeper on NCT03229265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03229265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call